ARCHIVES

Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Role Broadened By Upton; Asked To Consider All Data In Risk Assessment

November 11, 1977

Robert Cook-Deegan’s Viewers’ Guide To the Super Bowl of Gene Patent Cases

March 14, 2014

Geography Still An Issue For Centers: Durant Asks Is It “Holy Water” or Money

April 26, 1985

Bioassay Backlog To Be Cleared Up In Year: Squire

November 26, 1976

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

NCI Directory Delayed

January 27, 1984